Posttranslationally Modified Fetuin-A in Urine as a Marker for Renal Dysfunction (Patients With Chronic Kidney Disease - With or Without Kidney Transplantation).

Enrolling by invitationOBSERVATIONAL
Enrollment

86

Participants

Timeline

Start Date

June 25, 2024

Primary Completion Date

July 25, 2025

Study Completion Date

July 25, 2025

Conditions
Transplant Recipient (Kidney)Primary Kidney Transplantation
Interventions
DIAGNOSTIC_TEST

uPTM-FeA

In this monocentric prospective cohort study, we will measure uPTM-FeA by enzyme-linked immunosorbent assay (ELISA) kit DNLite IVD 103 in cooperation with PromedeusLab. Human uPTM3-DKD ELISA is a colourimetric immunoassay for quantitatively determining human unique Fetuin-A with specific post-translational modification (PTM) in urine.

Trial Locations (1)

03601

University Hospital Martin, Martin

All Listed Sponsors
lead

University Hospital, Martin

OTHER